Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan.

Saved in:
Bibliographic Details
Title: Beyond clinical trials: real-world impact of immunotherapy on NSCLC in Jordan.
Authors: Abu Hejleh T; Department of Internal Medicine, Medical Oncology, King Hussein Cancer Center, Amman, Jordan.; Department of Internal Medicine, Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa, Iowa City, IA, United States., AlSawalha K; Department of Internal Medicine, Medical Oncology, King Hussein Cancer Center, Amman, Jordan., Abdel Hafiz S; Department of Internal Medicine, Medical Oncology, King Hussein Cancer Center, Amman, Jordan., Al-Batsh T; Department of Internal Medicine, Medical Oncology, King Hussein Cancer Center, Amman, Jordan., Abu Hejleh R; Department of Internal Medicine, Medical Oncology, King Hussein Cancer Center, Amman, Jordan., Yaser S; Department of Internal Medicine, Medical Oncology, King Hussein Cancer Center, Amman, Jordan., Abu Jazar H; Department of Internal Medicine, Medical Oncology, King Hussein Cancer Center, Amman, Jordan., Khader J; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Alnsour A; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Mohamad I; Department of Radiation Oncology, King Hussein Cancer Center, Amman, Jordan., Abdel Jalil R; Department of Surgery, Thoracic Surgery, King Hussein Cancer Center, Amman, Jordan., Abu-Shanab A; Department of Surgery, Thoracic Surgery, King Hussein Cancer Center, Amman, Jordan., Gharaibeh A; Department of Radiology, King Hussein Cancer Center, Amman, Jordan., Abu Shattal M; Department of Radiology, King Hussein Cancer Center, Amman, Jordan., Alibraheem A; Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan., Haddad H; Department of Pathology, King Hussein Cancer Center, Amman, Jordan., Mahmoud N; Department of Internal Medicine, Pulmonary and Critical Care Medicine, King Hussein Cancer Center, Amman, Jordan., Obeidat S; Department of Internal Medicine, Pulmonary and Critical Care Medicine, King Hussein Cancer Center, Amman, Jordan., Al-Jaghbeer MJ; Department of Internal Medicine, Pulmonary and Critical Care Medicine, King Hussein Cancer Center, Amman, Jordan., Furqan M; Department of Internal Medicine, Hematology, Oncology and Blood and Marrow Transplantation, University of Iowa, Iowa City, IA, United States., Cortellini A; Operative Research Unit of Medical Oncology, Fondazione Policlinico Universitario Campus Bio-Medico, Rome, Italy.; Department of Surgery and Cancer, Imperial College London, London, United Kingdom., Velcheti V; Grossman School of Medicine, New York University, New York, NY, United States., Al-Rabi K; Department of Internal Medicine, Medical Oncology, King Hussein Cancer Center, Amman, Jordan.; School of Medicine, University of Jordan, Amman, Jordan.
Source: Frontiers in oncology [Front Oncol] 2024 Apr 30; Vol. 14, pp. 1369126. Date of Electronic Publication: 2024 Apr 30 (Print Publication: 2024).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101568867 Publication Model: eCollection Cited Medium: Print ISSN: 2234-943X (Print) Linking ISSN: 2234943X NLM ISO Abbreviation: Front Oncol Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2234-943X
DOI:10.3389/fonc.2024.1369126